Next, we evaluated whether interference with the CD47-SIRPα interaction could increase the phagocytic activity of macrophages against RCC cells using the CD47-blocking antibody IMC-002 (Fig. 2a). This evidence concerns the gene SIRPA and renal cell carcinoma.